Skip to main content
Top
Published in: Calcified Tissue International 5/2004

01-11-2004

Paget’s Disease of Bone in New Zealand: Continued Decline in Disease Severity

Authors: H. R. Cundy, G. Gamble, D. Wattie, M. Rutland, T. Cundy

Published in: Calcified Tissue International | Issue 5/2004

Login to get access

Abstract

We have reported previously that severe Paget’s disease of bone had become less common at our center between 1973 and 1993. Data from several countries support the view that there are important secular trends in the prevalence and severity of Paget’s disease. In this paper we describe recent trends in the demography of newly referred patients with Paget’s disease to determine if the secular trend toward milder disease has continued. A database of all newly referred patients (n = 1487) with Paget’s disease (1973 to 2002 inclusive, 30 years) was examined. Of these, 832 subjects (56%) had scintiscans. Plasma total alkaline phosphatase (total ALP) activity, disease extent on scintiscan, and a derived index of average ALP activity of pagetic bone were used as indices of severity. The number of new referrals with Paget’s disease declined sharply from 1994 onward and is currently at half the rate seen 20 years earlier, while the mean age at presentation has progressively increased by 4 years per decade (P < 0.0001). Total ALP at diagnosis, disease extent on scintiscan, and the number of bones involved were all negatively correlated with both date of birth (P < 0.0001) and year of presentation (P < 0.0001), indicating that more recently born and presenting subjects had substantially less severe bone disease. The average activity of pagetic bone was only weakly correlated with year of presentation, but not with year of birth or age at presentation. Although there are a number of potential biases, these data are consistent with a continued secular trend to presentation in older subjects with less extensive skeletal involvement, and a declining prevalence of Paget’s disease.
Literature
1.
go back to reference Kanis, JA 1991 Pathophysiology and treatment of Paget’s disease of boneMartin DunitzLondon Kanis, JA 1991 Pathophysiology and treatment of Paget’s disease of boneMartin DunitzLondon
2.
go back to reference Barker, DJP 1981The epidemiology of Paget’s diseaseMetab Bone Dis Rel Res3231234CrossRef Barker, DJP 1981The epidemiology of Paget’s diseaseMetab Bone Dis Rel Res3231234CrossRef
3.
go back to reference Detheridge, FM, Guyer, PB, Barker, DIP 1982European distribution of Paget’s diseaseBMJ28510051008PubMed Detheridge, FM, Guyer, PB, Barker, DIP 1982European distribution of Paget’s diseaseBMJ28510051008PubMed
4.
go back to reference Reasbeck, JC, Goulding, A, Campbell, DR, Beale, LR, Stewart, RDH 1983Radiological prevalence of Paget’s disease in New ZealandBMJ2861937 Reasbeck, JC, Goulding, A, Campbell, DR, Beale, LR, Stewart, RDH 1983Radiological prevalence of Paget’s disease in New ZealandBMJ2861937
5.
go back to reference Gardner, MJ, Guyer, PB, Barker, 1978Radiological prevalence of Paget’s disease of bone in British migrants to AustraliaBMJ. 16551657 Gardner, MJ, Guyer, PB, Barker,  1978Radiological prevalence of Paget’s disease of bone in British migrants to AustraliaBMJ. 16551657
6.
go back to reference Laurin, N, Brown, JP, Morissette, J, Raymond, V 2002Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone; AmJ Hum. Genet7015821588 Laurin, N, Brown, JP, Morissette, J, Raymond, V 2002Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone; AmJ Hum. Genet7015821588
7.
go back to reference Hocking, LJ, Lucas, GJA, Daroszewska, A, Mangion, J, Olavesen, M, Cundy, T, Nicholson, GC, Ward, L, Bennett, ST, Wuyts, W, Hul, W, Ralston, SH 2002Domain specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s diseaseHum Mol Gen1127352739 Hocking, LJ, Lucas, GJA, Daroszewska, A, Mangion, J, Olavesen, M, Cundy, T, Nicholson, GC, Ward, L, Bennett, ST, Wuyts, W, Hul, W, Ralston, SH 2002Domain specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s diseaseHum Mol Gen1127352739
8.
go back to reference Johnson-Pais, TL, Wisdom, JH, Weldon, KS, Cody, JD, Hansen, MF, Singer, FR, Leach, RJ 2003Three novel mutations in SQSTM1 identified in familial Paget’s disease of boneJ Bone Miner Res300-1817481753 Johnson-Pais, TL, Wisdom, JH, Weldon, KS, Cody, JD, Hansen, MF, Singer, FR, Leach, RJ 2003Three novel mutations in SQSTM1 identified in familial Paget’s disease of boneJ Bone Miner Res300-1817481753
9.
go back to reference Cundy, T, McAnulty, K, Wattle, D, Gamble, G, Rutland, M, Ibbertson, HK 1997Evidence for secular change in Paget’s diseaseBone206971CrossRefPubMed Cundy, T, McAnulty, K, Wattle, D, Gamble, G, Rutland, M, Ibbertson, HK 1997Evidence for secular change in Paget’s diseaseBone206971CrossRefPubMed
10.
go back to reference Coutris, G, Cayla, J, Rondier, J, Talbot, JN, Bonvarlet, JP, Milhaud, G 1975Analyse des perturbations des voies principales du metabolisme calcique dans la de Paget’sRev Rhum Mal Osteoartic42757759 Coutris, G, Cayla, J, Rondier, J, Talbot, JN, Bonvarlet, JP, Milhaud, G 1975Analyse des perturbations des voies principales du metabolisme calcique dans la de Paget’sRev Rhum Mal Osteoartic42757759
11.
go back to reference Doyle, T, Gunn, J, Anderson, G, Cundy, T 2002Paget’s disease in New Zealand: evidence for declining prevalenceBone31616619CrossRefPubMed Doyle, T, Gunn, J, Anderson, G, Cundy, T 2002Paget’s disease in New Zealand: evidence for declining prevalenceBone31616619CrossRefPubMed
12.
go back to reference Cundy, T, Wattie, D, Busch, S, Rutland, M, Ibbertson, HK 1999Paget’s disease in New Zealand: is it changing?Bone247s9sCrossRefPubMed Cundy, T, Wattie, D, Busch, S, Rutland, M, Ibbertson, HK 1999Paget’s disease in New Zealand: is it changing?Bone247s9sCrossRefPubMed
13.
go back to reference Cooper, C, Schafheutle, K, Kellingray, S, Guyer, P, Barker, D 2002The epidemiology of Paget’s disease in Britain—is the prevalence decreasing?J Bone Miner Res14192197 Cooper, C, Schafheutle, K, Kellingray, S, Guyer, P, Barker, D 2002The epidemiology of Paget’s disease in Britain—is the prevalence decreasing?J Bone Miner Res14192197
14.
go back to reference Staa, TP, Selby, P, Leufkens, HGM, Lyles, K, Sprafka, JM 2002Incidence and natural history of Paget’s disease of bone in England and WalesJ Bone Miner Res17465471PubMed Staa, TP, Selby, P, Leufkens, HGM, Lyles, K, Sprafka, JM 2002Incidence and natural history of Paget’s disease of bone in England and WalesJ Bone Miner Res17465471PubMed
15.
go back to reference Morales-Piga, AA, Bachiller-Corral, FJ, Abraira, V, Beltran, J, Rapado, A 2002Is clinical expressiveness of Paget’s disease of bone decreasing?Bone30399403CrossRefPubMed Morales-Piga, AA, Bachiller-Corral, FJ, Abraira, V, Beltran, J, Rapado, A 2002Is clinical expressiveness of Paget’s disease of bone decreasing?Bone30399403CrossRefPubMed
16.
go back to reference Gardner, MJ, Barker, DIP 1978Mortality from malignant tumours of bone and Paget’s disease in the United Sates and England and WalesInt J Epidemiol7121130PubMed Gardner, MJ, Barker, DIP 1978Mortality from malignant tumours of bone and Paget’s disease in the United Sates and England and WalesInt J Epidemiol7121130PubMed
17.
go back to reference O’Driscoll, JB, Anderson, DC 1985Pasts pets and Paget’s diseaseLancetii919921CrossRef O’Driscoll, JB, Anderson, DC 1985Pasts pets and Paget’s diseaseLancetii919921CrossRef
18.
go back to reference Dickinson, CJ 1999Mouth bacteria as the cause of Paget’s disease of boneMed Hypotheses52209212CrossRefPubMed Dickinson, CJ 1999Mouth bacteria as the cause of Paget’s disease of boneMed Hypotheses52209212CrossRefPubMed
19.
go back to reference Lever, JH 2002Paget’s disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesisBone31434436CrossRefPubMed Lever, JH 2002Paget’s disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesisBone31434436CrossRefPubMed
20.
go back to reference Siris, E 1994Epidemiological aspects of Paget’s disease: family history and relationship to other medical conditionsSemin Arth Rheum23222225CrossRef Siris, E 1994Epidemiological aspects of Paget’s disease: family history and relationship to other medical conditionsSemin Arth Rheum23222225CrossRef
21.
go back to reference Solomon, LR 1979Billiard-player’s fingers: an unusual case of Paget’s disease of boneBMJ1931 Solomon, LR 1979Billiard-player’s fingers: an unusual case of Paget’s disease of boneBMJ1931
22.
go back to reference Mee, AP, Dixon, JA, Hoyland, JA, Davies, M, Selby, PL, Mawer, EB 1998Detection of canine distemper virus in 100% of Paget’s disease samples by in situ-reverse transcriptase-polymerase chain reactionBone23171175CrossRefPubMed Mee, AP, Dixon, JA, Hoyland, JA, Davies, M, Selby, PL, Mawer, EB 1998Detection of canine distemper virus in 100% of Paget’s disease samples by in situ-reverse transcriptase-polymerase chain reactionBone23171175CrossRefPubMed
23.
go back to reference Friedrichs, WE, Reddy, SV, Bruder, JM, Cundy, T, Cornish, J, Singer, FR, Roodman, GD 2002Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget’s diseaseJ Bone Miner Res17145151PubMed Friedrichs, WE, Reddy, SV, Bruder, JM, Cundy, T, Cornish, J, Singer, FR, Roodman, GD 2002Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget’s diseaseJ Bone Miner Res17145151PubMed
24.
go back to reference Kurihara, N, Reddy, SV, Menaa, C, Anderson, D, Roodman, GD 2000Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotypeJ Clin Invest105607614PubMed Kurihara, N, Reddy, SV, Menaa, C, Anderson, D, Roodman, GD 2000Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotypeJ Clin Invest105607614PubMed
25.
go back to reference Ooi, CG, Walsh, CA, Gallagher, JA, Fraser, WD 2000Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget’s disease of boneBone27417421CrossRefPubMed Ooi, CG, Walsh, CA, Gallagher, JA, Fraser, WD 2000Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget’s disease of boneBone27417421CrossRefPubMed
26.
go back to reference Helfrich, MH, Hobson, RP, Grabowski, PS, Zurbriggen, A, Cosby, SL, Dickson, GR, Fraser, WD, Ooi, CG, Selby, PL, Crisp, AJ, Wallace, RG, Kahn, S, Ralston, SH 2000A negative search for a paramyxoviral etiology of Paget’s disease of bone: molecular, immunological, and ultrastructural studies in UK patientsJ Bone Miner Res1523152329PubMed Helfrich, MH, Hobson, RP, Grabowski, PS, Zurbriggen, A, Cosby, SL, Dickson, GR, Fraser, WD, Ooi, CG, Selby, PL, Crisp, AJ, Wallace, RG, Kahn, S, Ralston, SH 2000A negative search for a paramyxoviral etiology of Paget’s disease of bone: molecular, immunological, and ultrastructural studies in UK patientsJ Bone Miner Res1523152329PubMed
27.
go back to reference Rima, BK, Gassen, U, Helfrich, MH, Ralston, SH 2002The pro and con of measles virus in Paget’s disease: conJ Bone Miner Res1722902292PubMed Rima, BK, Gassen, U, Helfrich, MH, Ralston, SH 2002The pro and con of measles virus in Paget’s disease: conJ Bone Miner Res1722902292PubMed
Metadata
Title
Paget’s Disease of Bone in New Zealand: Continued Decline in Disease Severity
Authors
H. R. Cundy
G. Gamble
D. Wattie
M. Rutland
T. Cundy
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 5/2004
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0281-z

Other articles of this Issue 5/2004

Calcified Tissue International 5/2004 Go to the issue

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.